Jacqueline Elizabeth Shea, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), sold 90,098 shares at $12.01 ($1.1M) on 2021-01-27, disclosed to the SEC on 2021-01-29.
Open-market sale of $1.1M INO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 22,376 | $269K | 24.8% |
| 2 | $12.01 | 22,376 | $269K | 24.8% |
| 3 | $12.04 | 5,960 | $72K | 6.6% |
| 4 | $12.04 | 5,960 | $72K | 6.6% |
| 5 | $12.04 | 16,713 | $201K | 18.6% |
| 6 | $12.04 | 16,713 |
| $201K |
| 18.6% |
| Total | $12.03 avg | 90,098 | $1.1M | 100% |
| Filing → |
| INO | SELL | 2021-03-12 | $340K | — | Filing → |
| INO | SELL | 2021-02-03 | $763K | — | Filing → |